Patient Assistance Program

NEXAVAR Patient Assistance Program (NexPAP) is to assist Malaysian patients who have been diagnosed with hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC) and radioactive-refractory differentiated thyroid carcinoma (DTC).

 

STIVARGA Patient Assistance Program (StivargaPAP) is to assist Malaysian who have been diagnosed with metastatic colorectal cancer (CRC) and locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST).

 

This is a joint program between Bayer Malaysia and the Malaysian Liver Foundation (MLF).

MALAYSIAN LIVER FOUNDATION © 2015 All Rights Reserved